Zoetis Inc (ZTS)
153.11
+1.17
(+0.77%)
USD |
NYSE |
Apr 18, 16:00
153.28
+0.17
(+0.11%)
After-Hours: 20:00
Zoetis Cash from Operations (TTM): 2.353B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.353B |
September 30, 2023 | 2.197B |
June 30, 2023 | 1.999B |
March 31, 2023 | 2.152B |
December 31, 2022 | 1.912B |
September 30, 2022 | 1.85B |
June 30, 2022 | 1.977B |
March 31, 2022 | 2.122B |
December 31, 2021 | 2.213B |
September 30, 2021 | 2.252B |
June 30, 2021 | 2.161B |
March 31, 2021 | 2.118B |
December 31, 2020 | 2.126B |
September 30, 2020 | 1.99B |
June 30, 2020 | 1.934B |
March 31, 2020 | 1.814B |
December 31, 2019 | 1.795B |
September 30, 2019 | 1.797B |
June 30, 2019 | 1.841B |
March 31, 2019 | 1.79B |
December 31, 2018 | 1.79B |
September 30, 2018 | 1.814B |
June 30, 2018 | 1.703B |
March 31, 2018 | 1.616B |
December 31, 2017 | 1.346B |
Date | Value |
---|---|
September 30, 2017 | 1.024B |
June 30, 2017 | 824.00M |
March 31, 2017 | 781.00M |
December 31, 2016 | 713.00M |
September 30, 2016 | 705.00M |
June 30, 2016 | 670.00M |
March 31, 2016 | 655.00M |
December 31, 2015 | 664.00M |
September 30, 2015 | 773.00M |
June 30, 2015 | 672.00M |
March 31, 2015 | 709.00M |
December 31, 2014 | 626.00M |
September 30, 2014 | 537.00M |
June 30, 2014 | 548.00M |
March 31, 2014 | 377.00M |
December 31, 2013 | 681.00M |
September 30, 2013 | 693.00M |
June 30, 2013 | 653.00M |
March 31, 2013 | 739.00M |
December 31, 2012 | 454.00M |
September 30, 2012 | 258.00M |
June 30, 2012 | 365.00M |
March 31, 2012 | 430.00M |
December 31, 2011 | 497.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
1.795B
Minimum
Dec 2019
2.353B
Maximum
Dec 2023
2.032B
Average
1.999B
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
Biogen Inc | 1.547B |
Eli Lilly and Co | 4.240B |
Pfizer Inc | 8.70B |
Abbott Laboratories | 7.261B |
Bristol-Myers Squibb Co | 13.86B |